Sees FY25 non-GAAP gross margin of 76%-78%, FY25 non-GAAP R&D expense of $90M-$105M, and FY25 non-GAAP SG&A expense of $290M-$320M.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCRX: